PTU - Polskie Towarzystwo Urologiczne
home page
current numbers
archival numbers
list of articles:
list przewodni/covering letter
editor
Scientific Committee
publisher
subscription
advertising
important links

Estrogens in urinary incontinence in women during menopausal period
Article published in Urologia Polska 2005/58/4.

authors

Grzegorz Stachowiak
Klinika Ginekologii i Chorób Menopauzy w Instytucie Centrum Zdrowia Matki Polki w Łodzi
Kierownik kliniki: prof. dr hab. Tomasz Pertyński

keywords

urinary tract, urinary incontinence, menopause, estrogens

summary

Urinary incontinence (UI) is a frequent disease in menopausal women. Low menopausal estrogen levels are responsible for many disadvantageous changes of urogenital organs which results in urinary continence impairment. Intravaginal estrogen therapy, reversing atrophic lesions of lower urogenital tracts, seems to be an useful tool in the treatment of most UI cases in women after menopause.

references

  1. Lorenc RS, Walecki J: Diagnostyka osteoporozy. Springer PWN. Warszawa, 1998, 23-38.
  2. van Baal WM, Emeis JJ, Kenemans P et al: Short-term hormone replacement therapy: reduced plasma levels of soluble adhesion molecules. Eur J Clin Invest 1999, 29, 913-921.
  3. Schnaper HW, McGuire J, Runyan C et al: Sex steroids and the endothelium. Curr Med Chem 2000, 7, 519-531.
  4. Jensen M: Health consequences of fat distribution. Horm Res 1997, 48, 88-92.
  5. Tatoń J: Patofizjologia molekularna otyłości i jej znaczenie dla klinicysty. Med Metabol 1997, 1, 13-15.
  6. Colditz GA, Willett WC, Stampfer FE et al: Menopause and the risk of coronary heart disease in women. N Engl J Med 1987, 316, 1105-1110.
  7. Dembińska-Kieć A: Gospodarka lipidowa po menopauzie. Pol Arch Med Wewn 1998, 100, 211-219.
  8. Grodstein F, Stampfer MJ, Manson JE et al: Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. N Engl J Med 1996, 335, 453-461.
  9. Stachowiak G, Połać I, Jędrzejczyk S i in: Postmenopausal status, coagulation and fibrinolysis. Pol J Gynaecol Invest 2001, 3, 97-100.
  10. Tołłoczko T: Nietrzymanie moczu ? problem społeczny i kliniczny. Terapia 2002, 4, 4-6.
  11. Wilson L, Bron JS, Shin GP et al: Annual direct costs of urinary incontinence. Obstet Gynecol 2001, 98, 398-406.
  12. Hunskaar S, Lose G, Sykes D, Voss S: The prevalence of urinary incontinence in women in four European countries. BJU Int 2004, 93, 324-330.
  13. Barlow DH, Cardozo LD, Francis RM: Urogenital ageing and its effect on sexual health in older British women. Br J Obstet Gynaecol 1997, 104, 87-91.
  14. Płachta Z, Mazur P, Walaszek P i in: Nietrzymanie moczu u kobiet ? epidemiologia i czynniki ryzyka. Przeg Menop 2002, 1, 28-32.
  15. Bump RC. Discussion: Epidemiology of urinary incontinence. Urology 1997, 50, 15-16.
  16. Milsom I, Ekelund P, Molander U et al: The influence of age, parity, oral contraception, hysterectomy and menopause on the prevalence of urinary incontinence in women. J Urol 1993, 149, 1459-1462.
  17. Burgio KL, Matthews KA, Engel BT: Prevalence, incidence, and correlates of urinary incontinence in healthy, middle-aged women. J Urol 1991, 146, 1255-1259.
  18. Jolleys JV: Reported prevalence of urinary incontinence in general practice. Br Med J 1988, 296, 1300-1302.
  19. Vetter NJ, Jones DA, Victor CR: Urinary incontinence in the elderly at home. Lancet 198, 2, 1275-1277.
  20. Maggi A, Perez J: Role of female gonadal hormones in the CNS. Life Sci 1985, 37, 893-906.
  21. Blok BFM, Holstege G: Androgen receptor immunoreactive neurons in the hypothalamic preoptic area project to the pontine micturition center in the male cat. Neurourol Urodyn 1998, 17, 404-405.
  22. Pschyrembel W, Strauss G, Petri E: Ginekologia praktyczna. Wydawnictwo Lekarskie PZWL, Warszawa 1994.
  23. Swartz DP: Human reproduction. B. The menopause. [w: ] Practical points in gynaecology. Red. Swartz DP, Medical Examination Publishing Co., Inc. an Excerpta Medica Comp. New Hyde Park, New York 1984, 85-94.
  24. Oldenhave A: Some aspects of sexuality during the normal climacteric. [w:] Urogenital ageing. Red. von Schoultz B, The Partenon Publishing Group, New York, London 1994; 15-26.
  25. Postawski K: Menopauza a zmiany w układzie moczowo-płciowym. W: Klimakterium. Hormonalna terapia zastępcza. Poradnik terapeutyczny. Red. Jakowicki JA, Wydawnictwo BiFolium, Lublin 2001, 35-47.
  26. Stachowiak G, Małafiej E, Szczypkowska M, Pertyński T: Flora dróg rodnych u kobiet w okresie menopauzy. Pol Przegl Gin 2000, 2, 79-82.
  27. Blakeman PJ, Hilton P, Bulmer NJ: Mapping oestrogen and progesterone receptors throughout the female lower urinary tract. Neurourol Urodyn 1996, 15, 324-325.
  28. Smith P: Estrogens and the urogenital tract. Acta Obstet Gynecol Scand 1993, 72 (Suppl), 1-26.
  29. Bergman A, Karram MM, Bhatia NN: Changes in urethral cytology following estrogen administration. Gynecol Obstet Invest 1990, 29, 211-213.
  30. Blakeman PJ, Hilton P, Bulmer JN: Oestrogen status and cell cycle activity in the female lower urinary tract. Neurourol Urodyn 1996, 15, 325-326.
  31. McCallin PF, Taylor ES, Whitehead RW: A study of the changes in the urinary sediment during the menstrual cycle. Am J Obstet Gynecol 1950, 60, 64-74.
  32. Iosif CS, Batra S, Ek A et al: Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynecol 1981, 141, 817-820.
  33. Wilson PD, Barker G, Barnard RJ et al: Steroid hormone receptors in female lower urinary tract. Urol Int 1984, 39, 5-8.
  34. DeLancey JOL: Anatomy and physiology of urinary continence. Clin Obstet Gynecol 1990, 33, 298-305.
  35. Schwenzer T, Buth C, Degen W, Jahn K: Is there a correlation between the degree of proliferation of vaginal and urethral epithelium and the incidence of stress incontinence? A contribution to estrogen therapy in stress incontinence. Geburtshilfe Frauenheilkd 1987, 47, 158-64.
  36. Shapiro E: Effect of oestrogens on the weight and muscarinic receptor density of the rabbit bladder and urethra. J Urol 1986, 135, 1084-1087.
  37. Elliott RA, Castleden CM, Miodrag A, Kirwan P: The direct effects of diethylstilbestrol and nifedipine on the contractile responses of isolated human and rat detrusor muscles. Eur J Clin Pharmacol 1992, 43, 149-155.
  38. Boscia JA, Kaye D: Asymptomatic bacteria in the elderly. Infect Dis Clin North Am 1987, 1, 893-903.
  39. Methfessel HD, Richter H, Seliger E et al: Estrogen and progesterone receptors in mesenchymal structures of the female urogenital tract. Zentralbl Gynakol 1989, 111, 503-506.
  40. Rechberger T, Postawski K, Jakowicki J et al: The role of fascial collagen in stress urinary incontinence. Am J Obstet Gynecol 1998, 179, 1511-1514.
  41. Keane DP, Sims TJ, Abrams P et al: Analysis of collagen status in premenopausal nulliparous women with genuine stress incontinence. Br J Urol 1997, 104, 994-998.
  42. Versi E, Cardozzo LM, Brinacat M et al: Correlation of urethral physiology and skin collagen in postmenopausal women. Br J Obstet Gynaecol 1988, 95, 147-152.
  43. Falconer C, Ekman G, Malmstrom A et al: Decreased collagen synthesis in stress incontinent women. Obstet Gynecol 1994, 84, 583-586.
  44. Brincat M, Moniz CF, Studd JWW et al: Sex hormones and skin collagen content in postmenopausal women. Br Med J 1983, 287, 1337-1338.
  45. Prajsner A: Ocena czynnościowa dolnych dróg moczowych w różnych postaciach nietrzymania moczu u kobiet. Wiad Lek 2001, 54 (3-4), 164-170.
  46. Salmon UL, Walter RI, Gast SH: The use of estrogen in the treatment of dysuria and incontinence in postmenopausal women. Am J Obstet Gynecol 1941, 14, 23-31.
  47. Fantl JA, Cardozo LD, McClish DK et al: Estrogen therapy in the management of urinary incontinence in postmenopausal women ? a meta-analysis ? first report of the hormones and Urogenital Therapy Committee. Obstet Gynecol 1994, 83, 12-18.
  48. Hextall A, Bidmead J, Cardozo L et al: Hormonal influences on the human female lower urinary tract: a prospective evaluation of the effects of the menstrual cycle on symptomatology and the results of urodynamic investigation. Neurourol Urodyn 1999, 18, 363-364.
  49. van Geelen JM, Doesburg WH, Thomas CMG: Urodynamic studies in the normal menstrual cycle: the relationship between hormonal changes during the menstrual cycle and the urethral pressure profile. Am J Obstet Gynecol 1981, 141, 384-392.
  50. Chaliha C, Kalia V, Stanton SL et al: What does pregnancy and delivery do to bladder function? A urodynamic viewpoint. Neurourol Urodyn 1998, 17, 415-416.
  51. Cutner A [w:] The lower urinary tract in pregnancy. London, UK: University of London, 1993, 57-72.
  52. Fowler CJ, Christmas TJ, Chapple CR et al: Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome? BMJ 1988, 297, 1436-1438.
  53. Boos K, Hextall A, Cardozo L et al: Lower urinary tract symptoms and their impact on women with anorexia nervosa. Br J Obstet Gynaecol 1999, 106, 501-504.
  54. Wilson DP: Conservative management of urethral sphincter incompetence. Clin Obstet Gynecol 1990, 33, 330-345.
  55. Versi E, Cardoso LD: Urethral vascular pulsations. Proc. 15th Annual Meeting of the ICS 1985: 503.
  56. Bhatia NN, Bergman A, Karram MM: Effects of oestrogen on urethral function in women with urinary incontinence. Am J Obstet Gynecol 1989, 160, 176-181.
  57. Fantl JA, Wyman JF, Anderson RL: Postmenopausal urinary incontinence: comparison between non-estrogen and estrogen supplemented women. Obstet Gynecol 1988, 71, 823-828.
  58. Benness C, Gangar K, Cardozo LD et al: Do progestogens exacerbate urinary incontinence in women on HRT? Neurourol Urodyn 1991, 10, 316-8.
  59. Kirkengen AL, Anderson P, Gjersoe E et al: Oestriol in the prophylactic treatment of recurrent urinary tract infections in postmenopausal women. Scan J Prim Health Care 1992, 10, 139-142.
  60. Ishiko O, Hirai K, Sumi T et al: Hormone replacement therapy plus pelvic floor muscle exercise for postmenopausal stress incontinence ? a randomized, controlled trial. J Reprod Med 2001, 46, 213-220.
  61. Hilton P, Tweddel A, Mayne C: Oral and intravaginal estrogens alone and in combination with alpha adrenergic stimulation in genuine stress incontinence. Int Urogynecol J 1990, 12, 80-86.

correspondence

Grzegorz Stachowiak
Klinika Ginekologii i Chorób Menopauzy CZMP
ul. Rzgowska 281/289
93-338 Łódź
tel. (042) 271 15 07, 271 15 72
gstach23@interia.pl